🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering products of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, advertising, and consumer laws, risking fines, prosecution or prison.

Service Reaction and Material Removal

According to TikTok, the service has taken down problematic content and prohibited related hashtags and search suggestions. The company said it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.

Within moments of entering one group, a seller posted WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, posts show dark colored parcels with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet approved … may subject users to potentially serious health risks”.